Arunee Thongagkaraniroj, MD, M.Sc.
- Thermiva Vagina tightening
* Medical degree with first class honors from Chulalongkorn University, Thailand in 2009
* Master degree in Clinical Dermatology, Cardiff University, Wales in 2013
* Board Certified Bariatric Counselor (CBC), American Association of Bariatric Counselors, 2015
* Functional Medicine in Clinical Practice (IFMCP), Wuhan, China, 2016
Dr. Arunee Thongagkaraniroj is an Aesthetic specialist serving as a senior practitioner at one of Thailand’s leading Aesthetic Clinic, Romrawin, with numerous branches in Bangkok and other provinces. Moreover, she is a qualified professional trainer in facial design and body rejuvenation. Currently, she is pursuing Anti-aging Medicine at the Faculty of Anti-aging and Regenerative Program at Dhurakij Pundit University since 2015.
The application of transcutaneous temperature controlled radiofrequency (TTCRF) device for the treatment of vulvovaginal laxity in Thai women who previously had vaginal delivery.
Arunee Thongagkaraniroj M.D., Pakpilai Thavisin M.D., and Patana Teng-umnuay M.D., Ph.D.
Department of Anti-aging and Regenerative Medicine, Dhurakij Pundit University
Background: Vulvovaginal laxity and its associated symptoms (urinary incontinence, overactive bladder, atrophic vaginitis and sexual dysfunction) have a huge impact on women’s quality of life, mental wellness, partner relationship and social life. Transcutaneous temperature controlled radiofrequency (TTCRF) is one of the most effective and non-invasive procedure in treating these conditions with no downtime. The purpose of this study is to evaluate the application of TTCRF in treating vulvovaginal laxity and its associated symptoms with a single treatment/
Study Design: A prospective single-arm study. Method: This study included 10 Thai women aged 40-70 year-old who had at least 1 vaginal delivery. The degree of vulvovaginal laxity was reported by 7-point rating scale and its associated symptoms were evaluated by using questionnaires. The outcomes were recorded before, immediately after, and at 2 weeks, 1 month, and 3 months after the treatment.
Result: There was a significant improvement in degrees of vulvovaginal laxity after one treatment and last at least one month. The severity of vaginal dryness and the ability to maintain the lubrication during sexual activity were also improved for over 3 months. The severity of urinary incontinence and overactive bladder condition also improved. No side effects from the treatment were found. In addition, the overall satisfaction scores were high to very high.
Conclusions: A single treatment of vulvovaginal laxity using TTCRF device is safe and effective in correcting vulvovaginal laxity and its associated symptoms.